Zacks.com on MSN2d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine MenveoGSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
GlobalData on MSN2d
EC approves GSK’s Menveo vaccine presentation for IMDThe European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...
(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation. In 2022, the London ...
GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new ... Subscribe now to see this Premium News article from Alliance News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback